MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

For blood cancers, GlobalData’s Pharma Intelligence Center (PIC) lists 58 alloCAR-T products and 129 clinical trial programmes. Credit: Mesa Studios via Shutterstock. The development of

Take­da’s can­cer drug Iclusig scored an ac­cel­er­at­ed ap­proval in com­bi­na­tion with chemother­a­py from the FDA on Tues­day for new­ly-di­ag­nosed adults with Philadel­phia chro­mo­some-pos­i­tive acute lym­phoblas­tic